Search

Your search keyword '"Kauppila S"' showing total 115 results

Search Constraints

Start Over You searched for: Author "Kauppila S" Remove constraint Author: "Kauppila S"
115 results on '"Kauppila S"'

Search Results

1. New insights into the genetic etiology of Alzheimer's disease and related dementias

2. PB2271: GERMLINE LOSS OF RHOG IDENTIFIES ITS ROLE AS AN ESSENTIAL REGULATOR OF HUMAN LYMPHOCYTE CYTOTOXICITY

3. Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices

4. Incidence and clinicopathological features of follicular T-cell lymphoma in Finland:a population-based immunohistochemical study

6. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

8. Genetic architecture of human plasma lipidome and its link to cardiovascular disease

9. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer

11. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

12. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

13. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

14. Genetic Predisposition to In Situ and Invasive Lobular\ud Carcinoma of the Breast

17. Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype.

18. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas

30. Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

31. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas

32. Evaluation of neuroendocrine markers in renal cell carcinoma

33. Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma

34. Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis.

35. Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.

36. Common variants in breast cancer risk loci predispose to distinct tumor subtypes.

37. Incidence and clinicopathological features of Follicular T-cell lymphoma in Finland: a population-based immunohistochemical study.

38. Living conditions and mental wellness in a changing climate and environment: focus on community voices and perceived environmental and adaptation factors in Greenland.

39. RhoG deficiency abrogates cytotoxicity of human lymphocytes and causes hemophagocytic lymphohistiocytosis.

40. Exome sequencing identifies a recurrent variant in SERPINA3 associating with hereditary susceptibility to breast cancer.

41. Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma.

42. Tonsillar granuloma associated with hypogammaglobulinemia.

43. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.

44. Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.

45. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

46. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.

47. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.

48. Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.

49. Tumor infiltrating CD8 + T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma.

50. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

Catalog

Books, media, physical & digital resources